Zhengyang Li

Zhengyang focuses on capital markets and relevant merger & acquisitions transactions and compliance matters.

Representative matters:

Capital Markets

• Seres in its HK$14.28 billion initial public offering of H shares
• MetaLight Inc. in its HK$242.35 million initial public offering
• Zenergy in its HK$1 billion global initial public offering
• BrainAurora Medical Technology in its HK$538 million initial public offering and listing on the HKEX
• Gracell Biotechnologies on its private placement financing of up to $150 million
• ImmuneOnco Biopharmaceuticals on its HK$319 million global initial public offering and listing on the HKEX
• Bitdeer Technologies Group in its US$1.18 billion merger with Blue Safari (SPAC) and deSPAC listing on Nasdaq
• Laekna in its HK$791 million (US$101 million) initial public offering on HKEX
• YH Entertainment, the largest artist management company in China, on its HK$490 million IPO on HKEX
• Cryofocus Medtech in its HK$210 million ($27 million) initial public offering of 11,110,000 H Shares on the HKEX
• TI Cloud, a cloud-native customer contact solution provider, on its HK$559.4 million (US$71.7 million) IPO and listing on HKEX